Forte Biosciences Stock (NASDAQ: FBRX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 34.071K |
Day Range | - - - |
52 Wk Range | 0.380 - 1.150 |
Market Cap | $24.727M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 0.1% |
Days to Cover | 1.79 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Forte Biosciences (NASDAQ: FBRX) through any online brokerage.
Other companies in Forte Biosciences’s space includes: NKGen Biotech (NASDAQ:NKGN), Vincerx Pharma (NASDAQ:VINC), T2 Biosystems (NASDAQ:TTOO), Lumos Pharma (NASDAQ:LUMO) and Evaxion Biotech (NASDAQ:EVAX).
The latest price target for Forte Biosciences (NASDAQ: FBRX) was reported by Ladenburg Thalmann on Monday, April 8, 2024. The analyst firm set a price target for 2.75 expecting FBRX to rise to within 12 months (a possible 285.10% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Forte Biosciences (NASDAQ: FBRX) is $0.7141 last updated May 3, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Forte Biosciences.
Forte Biosciences’s Q1 earnings are confirmed for Friday, May 17, 2024.
There is no upcoming split for Forte Biosciences.
Forte Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.